Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-954-4 | CAS number: 1338-23-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.52 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor starting point:
- NOAEL
- Value:
- 51 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 62.9 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Standard respiratory volume, human (sRVhuman) for 8 h per person (70 kg): 6.7 m3
Standard respiratory volume of the rat (sRVrat) for 8 hours: 0.38 m3/kg bw
Worker respiratory volume (wRV) for 8 hours with light physical activity per person: 10 m3
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEC (inhalation) for workers:
NOAECcorr = NOAELoral x 1/0.38 m³/kg bw/day x 6.7 m³/10m³ x 7d/5d x ABSoral/ABSinh
NOAECcorr = 51 mg/kg bw/day x 0.5 x (1/0.38 m³/kg bw/day) x (6.7 m³/10 m³) x (7 days/ 5 days)
NOAECcorr = 51 mg/kg bw/day x 0.5 x 2.63 x 0.67 m³ x 1.4
NOAECcorr = 62.9 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- Extrapolation from subchronic to chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 7.55 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.43 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 51 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 142.8 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Using a conservative approach, a worker DNEL (long-term dermal exposure) is derived. Based on the physico-chemical properties of MEKP especially its high hydrophilicity (log Kow: 0.3 to 2.04 and water solubility: 6.5 g/L) dermal absorption is considered to be 50% of oral absorption.
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEL (dermal) for workers:
NOAELcorr = NOAELoral x 7d/5d x ABSoral/ABSinh
NOAELcorr = 51 mg/kg bw/day x 1.4 x 2
NOAELcorr = 142.8 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- Extrapolation from subchronic to chronic exposure.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
General
DNEL derivation for the test item is performed under consideration of the recommendations of ECHA (see references below).
Acute, systemic DNEL
The acute DNEL was calculated as 3 times the long-term DNEL, according to Guidance on information requirements and chemical safety assessment, chapter R.8: Characterisation of dose[concentration]-response for human health, November 2012.
Acute, systemic DNEL, inhalation: 7.55 mg/m3
Methyl-ethyl ketone peroxide (MEKP) is classified for acute oral and inhalation toxicity, cat. 4 according to Regulation (EC) No 1272/2008 (CLP). MEKP is not classified for systemic toxicity after acute inhalation and dermal exposure, according Regulation (EC) No 1272/2008 (CLP), based on the test data for acute dermal and inhalation toxicity. As workers are considered not to be exposed orally and no acute dermal hazard was identified, no acute worker DNEL for systemic effects after oral or dermal exposure is derived.
MEKP was further shown to have no skin sensitising potential. No qualitative assessment is required.
Acute/long term DNEL for local effects
Skin irritation/corrosion:
MEKP is classified as skin corrosive, cat 1B, H314 according to Regulation (EC) No 1272/2008 (CLP) based on the available experimental data. Therefore, a qualitative assessment is conducted.
Eye irritation:
MEKP causes severe eye damage, cat 1, H318 according to Regulation (EC) No 1272/2008 (CLP) based on the available experimental data. Therefore, a qualitative assessment is conducted.
Respiratory irritation:
MEKP causes severe skin burns and eye damage and signs of respiratory irritation were also observed in acute inhalation toxicity studies available. Therefore a qualitative assessment is conducted.
Appropriate qualitative risk managements measures should be implemented to avoid exposure. The substance is assigned to the medium hazard band in accordance with ECHA Guidance on information requirements and chemical safety assessment Part E: Risk Characterisation (2016).
Long term, systemic DNEL
Occupational exposure to MEKP occurs mainly by dermal route, and may also occur by inhalation exposure. Therefore two long-term DNELs are calculated for workers.
Exposure by inhalation
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2021) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the oral NOAEL in rats is 51 mg/kg bw/day.
Step 2: Modification into a correct starting point:
Using a conservative approach, a worker DNEL (long-term inhalation exposure) is derived.
Relevant dose descriptor (NOAEL): 51 mg/kg bw/day
Standard respiratory volume, human (sRVhuman) for 8 h per person (70 kg): 6.7 m3
Standard respiratory volume of the rat (sRVrat) for 8 hours: 0.38 m3/kg bw
Worker respiratory volume (wRV) for 8 hours with light physical activity per person: 10 m3
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEC (inhalation) for workers:
NOAECcorr = NOAELoral x 1/0.38 m³/kg bw/day x 6.7 m³/10m³ x 7d/5d x ABSoral/ABSinh
NOAECcorr = 51 mg/kg bw/day x 0.5 x (1/0.38 m³/kg bw/day) x (6.7 m³/10 m³) x (7 days/ 5 days)
NOAECcorr = 51 mg/kg bw/day x 0.5 x 2.63 x 0.67 m³ x 1.4
NOAECcorr = 62.9 mg/m³
Step 3: Use of assessment factors: 25
Intraspecies AF (worker): 5
The default value for the relatively homogenous group "worker" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 1
No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The OECD TG 443 toxicity study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic inhalation DNEL, workers = 2.52 mg/m3
Dermal exposure
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2021) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the oral NOAEL in rats is 51 mg/kg bw/day.
Step 2: Modification of the starting point:
Using a conservative approach, a worker DNEL (long-term dermal exposure) is derived. Based on the physico-chemical properties of MEKP especially its high hydrophilicity (log Kow: 0.3 to 2.04 and water solubility: 6.5 g/L) dermal absorption is considered to be 50% of oral absorption.
Correction for difference between human and experimental exposure conditions: 7 d rat/5 d worker
Corrected NOAEL (dermal) for workers:
NOAELcorr = NOAELoral x 7d/5d x ABSoral/ABSinh
NOAELcorr = 51 mg/kg bw/day x 1.4 x 2
NOAELcorr = 142.8 mg/kg bw/day
Step 3: Use of assessment factors: 100
Intraspecies AF (worker): 5
The default value for the relatively homogenous group "worker" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The OECD 443 study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic dermal DNEL, workers = 1.43 mg/kg bw/day
References
(not included as endpoint study record)
- ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health.
- ECHA (2014). Guidance on information requirements and chemical safety assessment. Chapter R.7c: Endpoint specific guidance, Guidance on Toxicokinetics.
- ECHA (2012) Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report, November 2012.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.44 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 51 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 22.17 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Standard respiratory volume of the rat (sRVrat) for 24 hours: 1.15 m3/kg bw/day
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Corrected NOAEC (inhalation) for general population:
NOAECcorr = NOAELoral x 1/1.15 m³/kg bw/day x ABSoral/ABSinh
NOAECcorr = 51 mg/kg bw/day x 0.87 x 0.5
NOAECcorr= 22.17 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- Extrapolation from subchronic to chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the more heterogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- irritation (respiratory tract)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.51 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 51 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 102 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Using a conservative approach, a general population DNEL (long-term dermal exposure) is derived. Based on the physico-chemical properties of MEKP especially its high hydrophilicity (log Kow: 0.3 to 2.04 and water solubility: 6.5 g/L) dermal absorption is considered to be 50% of oral absorption.
NOAELcorr = NOAELoral x ABSoral/ABSinh
NOAELcorr = 51 mg/kg bw/day * 2
NOAELcorr = 102 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- Extrapolation from subchronic to chronic exposure.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the more heterogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.26 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 51 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 51 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No modification is needed as the same route of exposure is assessed and the same exposure period is assumed.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 2
- Justification:
- Extrapolation from subchronic to chronic exposure.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the more heterogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
General
DNEL derivation for the test item is performed under consideration of the recommendations of ECHA (see references below).
Acute, systemic DNEL
Although MEKP is classified for acute oral and inhalation toxicity according to Regulation (EC) No 1272/2008, general population is intended to be exposed to peak concentrations neither via dermal, inhalation nor oral route. Therefore, no DNEL (short-term, inhalative, dermal and oral exposure) is derived for general population.
MEKP was further shown to have no skin sensitisation potential. No qualitative assessment is required.
Acute/long term DNEL for local effects
Skin irritation/corrosion:
MEKP is classified as skin corrosive, cat 1B, H314 according to Regulation (EC) No 1272/2008 (CLP) based on the available experimental data. Therefore, a qualitative assessment is conducted.
Eye irritation:
MEKP causes severe eye damage, cat 1, H318 according to Regulation (EC) No 1272/2008 (CLP) based on the available experimental data. Therefore, a qualitative assessment is conducted.
Respiratory irritation:
MEKP causes severe skin burns and eye damage and signs of respiratory irritation were also observed in acute inhalation toxicity studies available. Therefore a qualitative assessment is conducted.
Appropriate qualitative risk managements measures should be implemented to avoid exposure. The substance is assigned to the medium hazard band in accordance with ECHA Guidance on information requirements and chemical safety assessment Part E: Risk Characterisation (2016).
Long term, systemic DNEL
Everyday life exposure to MEKP occurs mainly by dermal route, and may also occur by inhalation and oral exposure. Therefore three long-term DNELs are calculated for the general population.
Exposure by inhalation
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2021) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the oral NOAEL in rats is 51 mg/kg bw/day.
Step 2: Modification into a correct starting point:
Using a conservative approach, a general population DNEL (long-term inhalation exposure) is derived.
Relevant dose descriptor (NOAEL): 51 mg/kg bw/day
Standard respiratory volume of the rat (sRVrat) for 24 hours: 1.15 m3/kg bw/day
Oral absorption of the rat/ inhalation absorption of humans (ABS oral-rat / ABS inh-human): 1/2 (default)
Corrected NOAEC (inhalation) for general population:
NOAECcorr = NOAELoral x 1/1.15 m³/kg bw/day x ABSoral/ABSinh
NOAECcorr = 51 mg/kg bw/day x 0.87 x 0.5
NOAECcorr = 22.17 mg/m³
Step 3: Use of assessment factors: 50
Intraspecies AF (general population): 10
The default value for the relatively heterogenous group "general population" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 1
No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The OECD TG 443 toxicity study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic inhalation DNEL, general population = 0.44 mg/m3
Dermal exposure
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2021) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the oral NOAEL in rats is 51 mg/kg bw/day.
Step 2: Modification of the starting point:
Using a conservative approach, a general population DNEL (long-term dermal exposure) is derived. Based on the physico-chemical properties of MEKP especially its high hydrophilicity (log Kow: 0.3 to 2.04 and water solubility: 6.5 g/L) dermal absorption is considered to be 50% of oral absorption.
NOAELcorr = NOAELoral x x ABSoral/ABSinh
NOAELcorr = 51 mg/kg bw/day * 2
NOAELcorr = 102 mg/kg bw/day
Step 3: Use of assessment factors: 200
Intraspecies AF (general population): 10
The default value for the relatively heterogenous group "general population" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic dermal DNEL, general population = 0.51 mg/kg bw/day
Oral exposure
Although MEKP has no bioaccumulation potential and no risk assessment for secondary poisoning is required an oral DNEL (long term, systemic) for the general population is derived.
Step 1: Selection of the relevant dose descriptor (starting point):
An EOGRTS according to OECD TG 443 (2021) is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the oral NOAEL in rats is 51 mg/kg bw/day.
Step 2: Modification of the starting point:
No corrections must be made. The PoD is 51 mg/kg bw/day
Step 3: Use of assessment factors: 200
Intraspecies AF (general population): 10
The default value for the relatively heterogenous group "general population" is used.
Interspecies AF, remaining differences: 2.5
The recommended AF for other interspecies differences is applied.
Allometric scaling AF: 4
The default allometric scaling factor for the differences between rats and humans is applied.
Dose response relationship AF: 1
The dose response relationship is considered unremarkable, therefore no additional factor is used.
Exposure duration AF: 2
Extrapolation from subchronic to chronic exposure.
Whole database AF: 1
The study was conducted according to regulatory standards and was adequately reported. On this basis the quality of the database is not considered to contribute uncertainty and it is therefore not necessary to apply an additional factor.
AF for remaining uncertainties: 1
DNEL Derivation is considered conservative, reflecting reasonable worst case assumptions. Therefore, no further AF for remaining uncertainties is applied.
In conclusion, long term systemic oral DNEL, general population = 0.26 mg/kg bw/day
References
(not included as endpoint study record)
- ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health.
- ECHA (2014). Guidance on information requirements and chemical safety assessment. Chapter R.7c: Endpoint specific guidance, Guidance on Toxicokinetics.
- ECHA (2012) Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report, November 2012.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.